Bringing you extra in 2018
The Cancer World team hopes that all our readers have had a good start to 2018. We look forward to bringing you critical, independent and rounded coverage of the big stories affecting quality cancer care [more]
The Cancer World team hopes that all our readers have had a good start to 2018. We look forward to bringing you critical, independent and rounded coverage of the big stories affecting quality cancer care [more]
A growing body of literature has described the so called “financial toxicity” of cancer, a common consequence of treatments, that sometimes leads patients to bankruptcy, and affects quality of life and clinical outcomes. “We don’t [more]
In the golden age of computing, both the present and future of medical decision-making seem to depend on new mathematical models and systems built around artificial intelligence (AI). But how will doctors and patients feel [more]
Some scholars recently coined the expression “Medical Misinformation Mess” to describe current clinical medicine as a realm in which it is very difficult to evaluate both reliability and practical meaning of research studies. A realm [more]
Clinical oncologists face many challenges to identify the best use of the anti-EGFR drugs in patients with non-small-cell-lung cancer. Thanks to genetic analysis, they are now able to identify responders from non-responders and to counteract [more]
Relief efforts aim at primary care, leaving refugees and displaced people with cancer without treatments or psychological support. In a worsening scenario, doctors are daily confronted with the hard choice between using the scarce resources [more]